Literature DB >> 31445275

Augmented intelligence with natural language processing applied to electronic health records for identifying patients with non-alcoholic fatty liver disease at risk for disease progression.

Tielman T Van Vleck1, Lili Chan2, Steven G Coca2, Catherine K Craven3, Ron Do4, Stephen B Ellis4, Joseph L Kannry5, Ruth J F Loos4, Peter A Bonis6, Judy Cho7, Girish N Nadkarni8.   

Abstract

OBJECTIVE: Electronic health record (EHR) systems contain structured data (such as diagnostic codes) and unstructured data (clinical documentation). Clinical insights can be derived from analyzing both. The use of natural language processing (NLP) algorithms to effectively analyze unstructured data has been well demonstrated. Here we examine the utility of NLP for the identification of patients with non-alcoholic fatty liver disease, assess patterns of disease progression, and identify gaps in care related to breakdown in communication among providers.
MATERIALS AND METHODS: All clinical notes available on the 38,575 patients enrolled in the Mount Sinai BioMe cohort were loaded into the NLP system. We compared analysis of structured and unstructured EHR data using NLP, free-text search, and diagnostic codes with validation against expert adjudication. We then used the NLP findings to measure physician impression of progression from early-stage NAFLD to NASH or cirrhosis. Similarly, we used the same NLP findings to identify mentions of NAFLD in radiology reports that did not persist into clinical notes.
RESULTS: Out of 38,575 patients, we identified 2,281 patients with NAFLD. From the remainder, 10,653 patients with similar data density were selected as a control group. NLP outperformed ICD and text search in both sensitivity (NLP: 0.93, ICD: 0.28, text search: 0.81) and F2 score (NLP: 0.92, ICD: 0.34, text search: 0.81). Of 2281 NAFLD patients, 673 (29.5%) were believed to have progressed to NASH or cirrhosis. Among 176 where NAFLD was noted prior to NASH, the average progression time was 410 days. 619 (27.1%) NAFLD patients had it documented only in radiology notes and not acknowledged in other forms of clinical documentation. Of these, 170 (28.4%) were later identified as having likely developed NASH or cirrhosis after a median 1057.3 days. DISCUSSION: NLP-based approaches were more accurate at identifying NAFLD within the EHR than ICD/text search-based approaches. Suspected NAFLD on imaging is often not acknowledged in subsequent clinical documentation. Many such patients are later found to have more advanced liver disease. Analysis of information flows demonstrated loss of key information that could have been used to help prevent the progression of early NAFLD (NAFL) to NASH or cirrhosis.
CONCLUSION: For identification of NAFLD, NLP performed better than alternative selection modalities. It then facilitated analysis of knowledge flow between physician and enabled the identification of breakdowns where key information was lost that could have slowed or prevented later disease progression.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  NAFLD; Natural language processing; Patient safety

Mesh:

Year:  2019        PMID: 31445275      PMCID: PMC6717556          DOI: 10.1016/j.ijmedinf.2019.06.028

Source DB:  PubMed          Journal:  Int J Med Inform        ISSN: 1386-5056            Impact factor:   4.046


  36 in total

1.  Physicians' use of electronic medical records: barriers and solutions.

Authors:  Robert H Miller; Ida Sim
Journal:  Health Aff (Millwood)       Date:  2004 Mar-Apr       Impact factor: 6.301

Review 2.  Incidental findings in imaging diagnostic tests: a systematic review.

Authors:  B Lumbreras; L Donat; I Hernández-Aguado
Journal:  Br J Radiol       Date:  2010-04       Impact factor: 3.039

Review 3.  From NAFLD in clinical practice to answers from guidelines.

Authors:  Fabio Nascimbeni; Raluca Pais; Stefano Bellentani; Christopher Paul Day; Vlad Ratziu; Paola Loria; Amedeo Lonardo
Journal:  J Hepatol       Date:  2013-06-07       Impact factor: 25.083

4.  iGAS: A framework for using electronic intraoperative medical records for genomic discovery.

Authors:  Matthew A Levin; Thomas T Joseph; Janina M Jeff; Rajiv Nadukuru; Stephen B Ellis; Erwin P Bottinger; Eimear E Kenny
Journal:  J Biomed Inform       Date:  2017-02-11       Impact factor: 6.317

5.  Validation of electronic medical record-based phenotyping algorithms: results and lessons learned from the eMERGE network.

Authors:  Katherine M Newton; Peggy L Peissig; Abel Ngo Kho; Suzette J Bielinski; Richard L Berg; Vidhu Choudhary; Melissa Basford; Christopher G Chute; Iftikhar J Kullo; Rongling Li; Jennifer A Pacheco; Luke V Rasmussen; Leslie Spangler; Joshua C Denny
Journal:  J Am Med Inform Assoc       Date:  2013-03-26       Impact factor: 4.497

6.  Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

Authors:  P Angulo; J C Keach; K P Batts; K D Lindor
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

7.  Translational Morphosyntax: Distribution of Negation in Clinical Records and Biomedical Journal Articles.

Authors:  K Bretonnel Cohen; Foster R Goss; Pierre Zweigenbaum; Lawrence E Hunter
Journal:  Stud Health Technol Inform       Date:  2017

8.  Diagnosis of genetic diseases in seriously ill children by rapid whole-genome sequencing and automated phenotyping and interpretation.

Authors:  Michelle M Clark; Amber Hildreth; Sergey Batalov; Yan Ding; Shimul Chowdhury; Kelly Watkins; Katarzyna Ellsworth; Brandon Camp; Cyrielle I Kint; Calum Yacoubian; Lauge Farnaes; Matthew N Bainbridge; Curtis Beebe; Joshua J A Braun; Margaret Bray; Jeanne Carroll; Julie A Cakici; Sara A Caylor; Christina Clarke; Mitchell P Creed; Jennifer Friedman; Alison Frith; Richard Gain; Mary Gaughran; Shauna George; Sheldon Gilmer; Joseph Gleeson; Jeremy Gore; Haiying Grunenwald; Raymond L Hovey; Marie L Janes; Kejia Lin; Paul D McDonagh; Kyle McBride; Patrick Mulrooney; Shareef Nahas; Daeheon Oh; Albert Oriol; Laura Puckett; Zia Rady; Martin G Reese; Julie Ryu; Lisa Salz; Erica Sanford; Lawrence Stewart; Nathaly Sweeney; Mari Tokita; Luca Van Der Kraan; Sarah White; Kristen Wigby; Brett Williams; Terence Wong; Meredith S Wright; Catherine Yamada; Peter Schols; John Reynders; Kevin Hall; David Dimmock; Narayanan Veeraraghavan; Thomas Defay; Stephen F Kingsmore
Journal:  Sci Transl Med       Date:  2019-04-24       Impact factor: 19.319

Review 9.  The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future.

Authors:  Omri Gottesman; Helena Kuivaniemi; Gerard Tromp; W Andrew Faucett; Rongling Li; Teri A Manolio; Saskia C Sanderson; Joseph Kannry; Randi Zinberg; Melissa A Basford; Murray Brilliant; David J Carey; Rex L Chisholm; Christopher G Chute; John J Connolly; David Crosslin; Joshua C Denny; Carlos J Gallego; Jonathan L Haines; Hakon Hakonarson; John Harley; Gail P Jarvik; Isaac Kohane; Iftikhar J Kullo; Eric B Larson; Catherine McCarty; Marylyn D Ritchie; Dan M Roden; Maureen E Smith; Erwin P Böttinger; Marc S Williams
Journal:  Genet Med       Date:  2013-06-06       Impact factor: 8.822

10.  Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States.

Authors:  Michael H Le; Pardha Devaki; Nghiem B Ha; Dae Won Jun; Helen S Te; Ramsey C Cheung; Mindie H Nguyen
Journal:  PLoS One       Date:  2017-03-27       Impact factor: 3.240

View more
  9 in total

Review 1.  Artificial Intelligence for Disease Assessment in Inflammatory Bowel Disease: How Will it Change Our Practice?

Authors:  Ryan W Stidham; Kento Takenaka
Journal:  Gastroenterology       Date:  2022-01-04       Impact factor: 22.682

2.  A Collaborative Framework Based for Semantic Patients-Behavior Analysis and Highlight Topics Discovery of Alcoholic Beverages in Online Healthcare Forums.

Authors:  Hamed Jelodar; Yongli Wang; Mahdi Rabbani; Gang Xiao; Ruxin Zhao
Journal:  J Med Syst       Date:  2020-04-07       Impact factor: 4.460

3.  A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank.

Authors:  Ryan W Walker; Gillian M Belbin; Elena P Sorokin; Tielman Van Vleck; Genevieve L Wojcik; Arden Moscati; Christopher R Gignoux; Judy Cho; Noura S Abul-Husn; Girish Nadkarni; Eimear E Kenny; Ruth J F Loos
Journal:  J Hepatol       Date:  2020-03-05       Impact factor: 25.083

4.  Natural language processing of electronic health records is superior to billing codes to identify symptom burden in hemodialysis patients.

Authors:  Lili Chan; Kelly Beers; Amy A Yau; Kinsuk Chauhan; Áine Duffy; Kumardeep Chaudhary; Neha Debnath; Aparna Saha; Pattharawin Pattharanitima; Judy Cho; Peter Kotanko; Alex Federman; Steven G Coca; Tielman Van Vleck; Girish N Nadkarni
Journal:  Kidney Int       Date:  2019-11-09       Impact factor: 10.612

5.  Artificial Intelligence for Understanding Imaging, Text, and Data in Gastroenterology.

Authors:  Ryan W Stidham
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-07

6.  Sepsis prediction, early detection, and identification using clinical text for machine learning: a systematic review.

Authors:  Melissa Y Yan; Lise Tuset Gustad; Øystein Nytrø
Journal:  J Am Med Inform Assoc       Date:  2022-01-29       Impact factor: 4.497

7.  Deep Learning Analysis of Polish Electronic Health Records for Diagnosis Prediction in Patients with Cardiovascular Diseases.

Authors:  Kristof Anetta; Ales Horak; Wojciech Wojakowski; Krystian Wita; Tomasz Jadczyk
Journal:  J Pers Med       Date:  2022-05-25

8.  External validation of a machine learning classifier to identify unhealthy alcohol use in hospitalized patients.

Authors:  Yiqi Lin; Brihat Sharma; Hale M Thompson; Randy Boley; Kathryn Perticone; Neeraj Chhabra; Majid Afshar; Niranjan S Karnik
Journal:  Addiction       Date:  2021-11-23       Impact factor: 7.256

9.  Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program.

Authors:  Marina Serper; Marijana Vujkovic; David E Kaplan; Rotonya M Carr; Kyung Min Lee; Qing Shao; Donald R Miller; Peter D Reaven; Lawrence S Phillips; Christopher J O'Donnell; James B Meigs; Peter W F Wilson; Rachel Vickers-Smith; Henry R Kranzler; Amy C Justice; John M Gaziano; Sumitra Muralidhar; Saiju Pyarajan; Scott L DuVall; Themistocles L Assimes; Jennifer S Lee; Philip S Tsao; Daniel J Rader; Scott M Damrauer; Julie A Lynch; Danish Saleheen; Benjamin F Voight; Kyong-Mi Chang
Journal:  PLoS One       Date:  2020-08-25       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.